Skip to main content
. 2019 Jan 2;18(2):167–172. doi: 10.1002/rmb2.12263

Table 1.

Characteristics of FPS and LPS

FPS (n = 29) LPS (n = 21) P
Age at OPU (y) 35.3 ± 4.0 37 ± 3.1 0.12
AMH (ng/mL) 3.8 ± 2.5 3.5 ± 2.5 0.66
Baseline FSH (mIU/mL) 8.0 ± 3.5 7.0 ± 3.2 0.28
Peak E2 (pg/mL) 595.2 ± 491.1 530.9 ± 538.1 0.66
Endometrial thickness (mm) 10.0 ± 2.0 11.3 ± 3.3 0.089
No. of follicles > 17 mm 2.6 ± 2.0 2.7 ± 2.6 0.84
Peak follicle size (mm) 19.2 ± 2.8 18.9 ± 2.6 0.74
No. of days stimulated 9.0 ± 1.9 11.3 ± 2.6 <0.001
Total FSH/HMG dose (IU) 1290.5 ± 586.2 1957.1 ± 1030.2 0.0056
No. of retrieved oocytes 8.7 ± 6.0 10.0 ± 6.8 0.48
Mature (MII) oocytes (%) 83.3 (125/150) 81.7 (49/60) 0.84
MI oocytes (%) 4.0 (6/150) 6.7 (4/60) 0.48
GV oocytes (%) 11.3 (17/150) 8.3 (5/60) 0.62
Degenerated oocytes (%) 1.3 (2/150) 3.3 (2/60) 0.32
Fertilization rate (%)
IVF 62.5 (35/56) 47.1 (48/102) 0.069
ICSI 70.3 (26/37) 90.0 (36/40) 1

FPS, follicular phase ovarian stimulation; GV, germinal vesicle; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilization; LPS, luteal phase ovarian stimulation; MI, metaphase I; MII, metaphase II; OPU, ovum pick up. Data are presented as mean ± SD. Mature oocytes were calculated in cases of oocyte cryopreservation (n = 28). Fertilization rate was calculated in cases of embryo cryopreservation (n = 25)